Abstract
Diffuse gliomas are the commonest malignant primary brain tumour in adults. Herein, we present analysis of the genomic landscape of adult glioma, by whole genome sequencing of 403 tumours (256 glioblastoma, 89 astrocytoma, 58 oligodendroglioma; 338 primary, 65 recurrence). We identify an extended catalogue of recurrent coding and non-coding genetic mutations that represents a source for future studies and provides a high-resolution map of structural variants, copy number changes and global genome features including telomere length, mutational signatures and extrachromosomal DNA. Finally, we relate these to clinical outcome. As well as identifying drug targets for treatment of glioma our findings offer the prospect of improving treatment allocation with established targeted therapies.
| Original language | English |
|---|---|
| Article number | 4233 |
| Journal | Nature Communications |
| Volume | 16 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 7 May 2025 |
ASJC Scopus subject areas
- General Chemistry
- General Biochemistry,Genetics and Molecular Biology
- General Physics and Astronomy
Keywords
- Adult
- Aged
- Astrocytoma/genetics
- Brain Neoplasms/genetics
- DNA Copy Number Variations
- Female
- Genome, Human
- Genomics
- Glioblastoma/genetics
- Glioma/genetics
- Humans
- Male
- Middle Aged
- Mutation
- Oligodendroglioma/genetics
- Telomere/genetics
- Whole Genome Sequencing